The Prevalence and Risk Factors for Neonatal Thrombocytopenia among Newborns Admitted to Intensive Care Unit of Aliasghar Children’s Hospital
Journal Title: Iranian Journal of Blood and Cancer - Year 2013, Vol 5, Issue 2
Abstract
Background: Determining the prevalence and risk factors of thrombocytopenia among neonates enables us to prevent the inevitable and sometimes irreversible complications. In this study we aimed to survey the frequency of thrombocytopenia and its demographic features and risk factors. Materials and methods: In this cross sectional study the platelet counts of 364 neonates admitted to neonatal intensive care unit of Aliasghar children’s hospital, Tehran, Iran, were assessed. Maternal and neonatal medical conditions, risk factors and drug history were also recorded. Patients were divided into 4 groups according to the severity of thrombocytopenia: mild (100-149 × 109/L), moderate (50-99 × 109/L), severe (30-49 × 109/L) and very severe (< 30 × 109/L).They were also grouped as presenting early (less than 72 hours after birth) and late (more than 72 hours after birth) thrombocytopenia. Demographic data and hemorrhagic manifestations were also recorded. Results: Sixty two (17.9%) of neonates were thrombocytopenic. The average gestational age at birth for the thrombocytopenic neonates was significantly lower than the non thrombocytopenic neonates (32.2 ±2.5 weeks versus 34.9± 2.5, P=0.0001), and also the average birth weight was significantly lower among the thrombocytopenic neonates (1979±517gr versus 2371±480 gr, P=0.0001). Neonatal sepsis was significantly associated with thrombocytopenia (24.1% versus 5.9%, P=0.0001). Conclusion: Our study indicated a high prevalence of thrombocytopenia among neonates admitted to NICU and its association with low birth weight, prematurity, and neonatal sepsis. Regarding the importance of life threatening events among the thrombocytopenic newborns, it is best to keep the risk factors in mind to prevent the future complications. Key words: Thrombocytopenia, risk factor, neonate, preterm
Authors and Affiliations
Nasrin Khalessi, Nastaran Khosravi, Sara Sanii, Fatemeh Zareh Mehrjerdi
Keywords
Related Articles
- EP ID EP365845
- DOI -
- Views 82
- Downloads 0
Side Effects of Hydroxyurea in Patients with Sickle Cell Anemia
hemoglobin in infancy plays a relatively protective role for vaso-occlusive symptoms that are the major contributor for the morbidity and mortality among patients with sickle cell anemia. hydroxyurea, an s-phase-specific...
Access and Rational use of Plasma Protein Therapies (PPTs)
This article has no abstract.
Infusible Platelet Membrane versus Conventional Platelet Concentrate: Benefits and Disadvantages
Blood transfusion centers are under considerable pressure to produce platelet concentrates with a shelf life limit of 3 to 5 days. Many approaches have been investigated experimentally to produce new hemostatically activ...
Association of Acute Lymphoblastic Leukemia and MDR1 Gene Polymorphism in an Ethnic Iranian Population
Background: The frequency of the multi-drug resistance 1 (MDR1) gene C3435T polymorphism differs in various ethnical populations such as Asian, African, and Caucasians populations. A silent C3435T polymorphism in exon 26...
Influences of Genetic Abnormality on the Risk of Acute Lymphoblastic Leukemia
ecent studies have provided evidence that common genetic variations could account for a proportion of leukemia in adult or children. To evaluate the contribution of candidate gene association studies to the understanding...